Chronic myeloid leukemia (CML) is a hematopoietic stem cell disorder characterized by BCR-ABL1, an oncogenic fusion gene arising from the Philadelphia chromosome. This evidence concerns the gene BCR and chronic myelogenous leukemia, BCR-ABL1 positive.